Samalin Investment Counsel, LLC Illumina, Inc. Transaction History

Samalin Investment Counsel, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$181.58 - $368.0 $52,476 - $106,352	-289 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$347.28 - $421.83 $15,627 - $18,982	-45 Reduced 13.47%	289 $110 Million
Q3 2021 Nov 15, 2021	BUY	$405.61 - $524.84 $1,216 - $1,574	3 Added 0.91%	334 $135 Million
Q2 2021 Aug 12, 2021	BUY	$372.84 - $481.5 $123,410 - $159,376	331 New	331 $156,000
Q1 2021 May 11, 2021	SELL	$361.28 - $504.76 $133,312 - $186,256	-369 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$268.51 - $400.74 $99,080 - $147,873	369 New	369 $114,000
Q1 2020 May 04, 2020	SELL	$209.2 - $335.53 $77,194 - $123,810	-369 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$288.29 - $335.49 $106,379 - $123,795	369 New	369 $122,000

900

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.4B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

Stay updated on Samalin Investment Counsel, LLC with notifications on news.